A. Nouri

发表

Profile of p53 expression in bladder and oral tumours. Effects of in vitro manipulations of p53 on the behaviour of established human tumour cell lines.

A. Nouri, H. Cannell, B. Dagini, 2000, European journal of cancer.

Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines.

A. Nouri, H. Cannell, Z. Amirghofran, 2000, International journal of molecular medicine.

A new approach for measurement of cytotoxicity using colorimetric assay.

A. Nouri, R. Oliver, R. Hussain, 1993, Journal of immunological methods.

Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line.

D. Perrett, A. Nouri, R. Oliver, 2001, Biomedical chromatography : BMC.

Isolation of Human Leukocyte Antigen (HLA)-Associated Peptide(s) in the Absence of HLA-Restricted Specific Cytolytic T Lymphocytes

A. Nouri, W. Morrow, R. Oliver, 2002, Urologia Internationalis.

Comparative Study between Direct Mild Acid Extraction and Immunobead Purification Technique for Isolation of HLA Class I-Associated Peptides

A. Nouri, R. Oliver, R. Saffie, 2002, Urologia Internationalis.

Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients

T. Lister, A. Nouri, R. Oliver, 2005, Cancer Immunology, Immunotherapy.

Cytokines and the chronic inflammation of rheumatic disease. II. The presence of interleukin-2 in synovial fluids.

S. Goodman, A. Nouri, G. Panayi, 1984, Clinical and experimental immunology.

Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.

P. Emery, A. Nouri, G. Panayi, 1984, Clinical and experimental immunology.

The relevance of p53 mutation in urological malignancies: possible clinical implications for bladder cancer.

A. Nouri, H. Cannell, R. Oliver, 1996, British journal of urology.

Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

S. Goodman, A. Nouri, G. Panayi, 1984, Clinical and experimental immunology.

Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.

A. Nouri, R. Oliver, M. Smith, 1990, British Journal of Cancer.

Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing.

A. Nouri, R. Oliver, R. Hussain, 1993, British Journal of Cancer.

Effect of Histamine and Related Compounds on the Immune Response

A. Nouri, D. Fan, D. Gordon, 1982 .

A new highly specific monoclonal antibody against placental alkaline phosphatase: a potential marker for the early detection of testis tumour

A. Nouri, A. Dabare, N. Torabi-Pour, 2000, BJU international.

Relevance of the immune system in human urological malignancies: prospective for future clinical treatments.

A. Nouri, M. Symes, 1998, Urology.

Voices in the Wilderness

A. Nouri, R. Oliver, D. Crosby, 1993, Environmental Health Perspectives.

Correlation between class I antigen expression and the ability to generate tumour infiltrating lymphocytes from bladder tumour biopsies.

A. Nouri, R. Oliver, D. Crosby, 1991, British Journal of Cancer.

Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.

J. Bodmer, A. Nouri, R. Oliver, 1993, European journal of cancer.

Induction of MHC antigens by tumour cell lines in response to interferons.

A. Nouri, R. Oliver, D. Gillott, 1992, European journal of cancer.

BIOLOGICAL SIGNIFICANCE OF BETA hCG, HLA AND OTHER MEMBRANE ANTIGEN EXPRESSION ON BLADDER TUMOURS AND THEIR RELATIONSHIP TO TUMOUR INFILTRATING LYMPHOCYTES (TIL)

W. Bodmer, A. Nouri, R. Oliver, 1989, Journal of immunogenetics.

Comparative Study of Peptides Isolated from Class I Antigen Groove of Urological Specimens

A. Nouri, R. Oliver, R. Saffie, 2002, Urologia Internationalis.

Comparison of the inhibition by glucocorticosteroids and cyclosporin A of mitogen-stimulated human lymphocyte proliferation.

A. Nouri, D. Gordon, 1981, Clinical and experimental immunology.

Super-sensitive epithelial cell line and colorimetric assay to replace the conventional K562 target and chromium release assay for assessment of non-MHC-restricted cytotoxicity.

A. Nouri, R. Oliver, R. Hussain, 1995, Journal of immunological methods.

Comparative expression of major histocompatibility complex (MHC) antigens on CD5+ and CD5- B cells in patients with chronic lymphocytic leukaemia (CLL)

M. Macey, A. Nouri, A. Newland, 1998, European journal of cancer.

Accurate and rapid assessment of MHC antigen upregulation following cytokine stimulation.

A. Nouri, R. Oliver, D. Gillott, 1993, Journal of immunological methods.

T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy.

A. Nouri, R. Oliver, 1992, Cancer surveys.

CORRELATION BETWEEN EXPRESSION OF CLASS I ANTIGEN AND DEVELOPMENT OF TUMOUR INFILTRATING LYMPHOCYTES (TILS) FROM TUMOUR BIOPSIES OF PATIENTS WITH BLADDER CANCER

A. Nouri, A. Shamsa, A. D. Santos, 1991 .

Evaluation of the effect of continuous infusion recombinant interleukin-2 (bioleukin) on peripheral blood leucocytes of patients with terminal malignancy.

A. Nouri, R. Oliver, A. Galazka, 1989, British Journal of Cancer.

Cytokines and the chronic inflammation of rheumatic disease. III. Deficient interleukin-2 production in rheumatoid arthritis is not due to suppressor mechanisms.

A. Nouri, G. Panayi, 1987, The Journal of rheumatology.

Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.

A. Nouri, D. Gordon, M. Edwards, 1983, Molecular Pharmacology.

TUMOUR‐PROMOTING AND NON‐PROMOTING PRO‐INFLAMMATORY PHORBOL ESTERS AS HUMAN LYMPHOCYTE MITOGENS

S. E. Taylor, A. Nouri, D. Gordon, 1981 .

INHIBITION OF LYMPHOCYTE PROLIFERATION BY HISTAMINE AND RELATED COMPOUNDS NOT MEDIATED VIA H1‐ OR H2‐ RECEPTORS

A. Nouri, D. Gordon, G. Lewis, 1981, British journal of pharmacology.

Human pregnancy serum inhibits interleukin-2 production.

A. Nouri, G. Panayi, N. S. Nicholas, 1984, Clinical and experimental immunology.

SELECTIVE INHIBITION OF THROMBOXANE BIOSYNTHESIS IN HUMAN BLOOD MONONUCLEAR CELLS AND THE EFFECTS ON MITOGEN‐STIMULATED LYMPHOCYTE PROLIFERATION

A. Nouri, D. Gordon, R. U. Thomas, 1981, British journal of pharmacology.

Profile of Placental Alkaline Phosphatase Expression in Human Malignancies: Effect of Tumour Cell Activation on Alkaline Phosphatase Expression

A. Nouri, H. Cannell, A. Dabare, 2000, Urologia Internationalis.

The possible relevance of the expression of MHC antigens and of EGF receptor in aggressive oral tumours.

A. Nouri, H. Cannell, R. Oliver, 1997, International Journal of Oncology.

A NEW CYTOCOLORIMETRIC ASSAY USING PHOSPHATAS E ACTIVI T Y FOR MEASURING CELLULAR FUNCTIONS

A. Nouri, A. Dabare, R. Oliver, 2000 .

The combined use of high performance liquid chromatography and immuno-biochemical techniques for protein isolation: a new approach for identification of an individual protein from a pool of proteins.

D. Perrett, A. Nouri, R. Oliver, 2000, Biomedical chromatography : BMC.

Paired tumour infiltrating lymphocyte (TIL) and tumour cell line from bladder cancer: a new approach to study tumour immunology in vitro.

E. Lederer, A. Nouri, R. Oliver, 1991, European journal of cancer.

Standardization and Potential Use of HPLC for Detection of Cellular Placental Alkaline Phosphatase Using Established Tumour Cell Lines and Fresh Tumour Biopsies

A. Nouri, R. Oliver, N. Torabi-Pour, 2000, Urologia Internationalis.

The frequency of major histocompatibility complex antigen abnormalities in urological tumours and their correction by gene transfection or cytokine stimulation.

A. Nouri, R. Oliver, R. Hussain, 1994, Cancer gene therapy.

Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.

A. Nouri, R. Oliver, B. Young, 2002, Cancer genetics and cytogenetics.

Epidermal growth factor-induced protection of tumour cell susceptibility to cytolysis.

A. Nouri, R. Oliver, R. Hussain, 1995, European journal of cancer.

Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancer

A. Nouri, R. Oliver, R. Hyde, 1994, Cancer Immunology, Immunotherapy.

Effects of anti-arthritic drugs on the release of mononuclear cell factors (MCF) that stimulate prostaglandin (PG) E2 production by rheumatoid synovial cells

A. Nouri, D. Gordon, R. Thomas, 1982 .